Filing Details
- Accession Number:
- 0001127602-10-000996
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-06 12:00:00
- Reporting Period:
- 2010-01-04
- Filing Date:
- 2010-01-06
- Accepted Time:
- 2010-01-06 18:03:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1097264 | Allos Therapeutics Inc | ALTH | Pharmaceutical Preparations (2834) | 541655029 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190418 | J Stephen Hoffman | 11080 Circlepoint Road Suite 200 Westminster CO 80020 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-04 | 25,428 | $2.42 | 500,298 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-04 | 25,428 | $6.54 | 474,870 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-01-05 | 45,428 | $2.42 | 520,298 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-05 | 45,428 | $6.64 | 474,870 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-01-06 | 45,429 | $2.42 | 520,299 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-06 | 45,429 | $6.78 | 474,870 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2010-01-04 | 25,428 | $0.00 | 25,428 | $2.42 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2010-01-05 | 45,428 | $0.00 | 45,428 | $2.42 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2010-01-06 | 45,429 | $0.00 | 45,429 | $2.42 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
227,143 | 2001-01-12 | 2010-01-12 | No | 4 | M | Direct |
181,715 | 2001-01-12 | 2010-01-12 | No | 4 | M | Direct |
136,286 | 2001-01-12 | 2010-01-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 400 | Indirect | Custodial Account |
Common Stock | 100 | Indirect | Custodial Account For Elizabeth Hoffman |
Common Stock | 100 | Indirect | Custodial Account For Margaret Hoffman |
Common Stock | 100 | Indirect | Custodial Account For Mary Evelyn Hoffman |
Common Stock | 100 | Indirect | Custodial Account For Michael Hoffman |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan and relate to the exercise of stock options which were scheduled to expire on January 12, 2010 and the sale of the underlying shares for tax and estate planning purposes.
- The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.50 to $6.6075. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.57 to $6.70. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $6.74 to $6.81. Upon request of the SEC staff, Allos Therapeutics Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.